CAD 0.03
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 877.9 Thousand CAD | 1.84% |
2022 | 862 Thousand CAD | -49.61% |
2021 | 1.71 Million CAD | 95.97% |
2020 | 872.95 Thousand CAD | 29.55% |
2019 | 673.84 Thousand CAD | 150.34% |
2018 | 269.17 Thousand CAD | -17.99% |
2017 | 328.21 Thousand CAD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 751.52 Thousand CAD | -20.64% |
2024 Q1 | 946.95 Thousand CAD | 7.87% |
2023 Q3 | 968.74 Thousand CAD | 38.41% |
2023 FY | 877.9 Thousand CAD | 1.84% |
2023 Q4 | 877.9 Thousand CAD | -9.38% |
2023 Q2 | 699.93 Thousand CAD | -10.08% |
2023 Q1 | 778.4 Thousand CAD | -9.7% |
2022 Q3 | 1.08 Million CAD | -17.12% |
2022 FY | 862 Thousand CAD | -49.61% |
2022 Q1 | 1.57 Million CAD | -8.14% |
2022 Q2 | 1.3 Million CAD | -17.0% |
2022 Q4 | 862 Thousand CAD | -20.26% |
2021 Q2 | 2.4 Million CAD | -1.85% |
2021 Q1 | 2.44 Million CAD | 180.51% |
2021 Q4 | 1.71 Million CAD | -27.68% |
2021 Q3 | 2.36 Million CAD | -1.57% |
2021 FY | 1.71 Million CAD | 95.97% |
2020 Q1 | 688.12 Thousand CAD | 2.12% |
2020 FY | 872.95 Thousand CAD | 29.55% |
2020 Q4 | 872.95 Thousand CAD | 24.91% |
2020 Q3 | 698.88 Thousand CAD | -1.14% |
2020 Q2 | 706.91 Thousand CAD | 2.73% |
2019 FY | 673.84 Thousand CAD | 150.34% |
2019 Q1 | 271.31 Thousand CAD | 0.8% |
2019 Q2 | 630.05 Thousand CAD | 132.22% |
2019 Q4 | 673.84 Thousand CAD | 5.2% |
2019 Q3 | 640.51 Thousand CAD | 1.66% |
2018 FY | 269.17 Thousand CAD | -17.99% |
2018 Q1 | - CAD | 0.0% |
2018 Q4 | 269.17 Thousand CAD | 0.0% |
2017 FY | 328.21 Thousand CAD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
AI/ML Innovations Inc. | 329.68 Thousand CAD | -166.284% |
Diagnamed Holdings Corp. | 662.27 Thousand CAD | -32.56% |
Pangenomic Health Inc. | 71.47 Thousand CAD | -1128.218% |
Treatment.Com International Inc. | 739.3 Thousand CAD | -18.747% |
Unidoc Health Corp. | 517.08 Thousand CAD | -69.78% |